Teleflex Incorporated Stock News

WAYNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m

Teleflex's (TFX) new UroLift 2 System with the ATC platform is designed to treat all prostate types.

Investors are optimistic about Teleflex (TFX) on robust growth in the Vascular business and strong Urolift prospects.

Teleflex (TFX) surpasses earnings and revenue estimates in the fourth quarter of 2023.

Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Stre

Teleflex (TFX) came out with quarterly earnings of $3.38 per share, beating the Zacks Consensus Estimate of $3.26 per share. This compares to earnings of $3.52 per share a year ago.

WAYNE, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 45th Annual Raymond James Institutional Investors

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WAYNE, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m

There are small-cap funds, and there are mid-cap funds, and those invest in both. These are what you call SMID-Cap funds.

Investors remain optimistic about Teleflex (TFX), backed by the strong prospects of the Interventional business and stable solvency.

WAYNE, Pa., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 42nd Annual J.P. Morgan Healthcare Conference at

Teleflex (TFX) secures the Peripheral Access purchasing agreement with Premier, Inc.

Teleflex stock (NYSE: TFX), which provides instruments and consumables for laboratories, trades at $220 per share, 50% below the level seen in March 2021.

Investors remain optimistic about Teleflex (TFX) on the strength of the Vascular and Interventional businesses.